Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

• Status: Terminated
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to investigate the effect of the treatment with the GLP-1 Analogon Liraglutide on the lipid metabolism an inflammation in adipose tissue.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf
• Treatments: Glucagon; Glucagon-Like Peptide 1; Liraglutide

Criteria

Inclusion Criteria:

• BMI 35-55 Kg/m2

• Fasting Blood glucose >140mg/dl

• Planned bariatric surgery

• Diabetic Medication (Metformin, Sulfonylurea, Insuline)

Exclusion Criteria:

• Known hypersensitivity against Liraglutid

• Pretreatment DPP-4 Inhibitors or GLP-1 Analogue the last 3 months

• HbA1c >10%